These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2900052)

  • 1. Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease.
    Cowburn R; Hardy J; Roberts P; Briggs R
    Brain Res; 1988 Jun; 452(1-2):403-7. PubMed ID: 2900052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease.
    Cowburn R; Hardy J; Roberts P; Briggs R
    Neurosci Lett; 1988 Mar; 86(1):109-13. PubMed ID: 2896322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional changes in [3H]D-aspartate and [3H]TCP binding sites in Alzheimer's disease brains.
    Simpson MD; Royston MC; Deakin JF; Cross AJ; Mann DM; Slater P
    Brain Res; 1988 Oct; 462(1):76-82. PubMed ID: 2846124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
    Chalmers DT; Dewar D; Graham DI; Brooks DN; McCulloch J
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding to the glycine site of the NMDA receptor complex in brains of patients with Alzheimer's disease.
    Del Bel EA; Slater P
    Neurosci Lett; 1991 Sep; 131(1):75-8. PubMed ID: 1838796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain.
    Monaghan DT; Cotman CW
    J Neurosci; 1985 Nov; 5(11):2909-19. PubMed ID: 2865341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl-D-aspartate receptors in the cortex and hippocampus of baboon (Papio anubis and Papio papio).
    Geddes JW; Cooper SM; Cotman CW; Patel S; Meldrum BS
    Neuroscience; 1989; 32(1):39-47. PubMed ID: 2573860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
    Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
    Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease.
    Geddes JW; Chang-Chui H; Cooper SM; Lott IT; Cotman CW
    Brain Res; 1986 Dec; 399(1):156-61. PubMed ID: 2879613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Region-specific loss of glutamate innervation in Alzheimer's disease.
    Hardy J; Cowburn R; Barton A; Reynolds G; Lofdahl E; O'Carroll AM; Wester P; Winblad B
    Neurosci Lett; 1987 Jan; 73(1):77-80. PubMed ID: 2882446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases.
    Cross AJ; Slater P; Simpson M; Royston C; Deakin JF; Perry RH; Perry EK
    Neurosci Lett; 1987 Aug; 79(1-2):213-7. PubMed ID: 2823192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular uptake disguises action of L-glutamate on N-methyl-D-aspartate receptors. With an appendix: diffusion of transported amino acids into brain slices.
    Garthwaite J
    Br J Pharmacol; 1985 May; 85(1):297-307. PubMed ID: 2862941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
    Maragos WF; Greenamyre JT; Chu DC; Penney JB; Young AB
    Brain Res; 1991 Jan; 538(1):36-45. PubMed ID: 1850317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.
    Cross AJ; Slater P; Reynolds GP
    Neurosci Lett; 1986 Jun; 67(2):198-202. PubMed ID: 2873534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease.
    Procter AW; Wong EH; Stratmann GC; Lowe SL; Bowen DM
    J Neurochem; 1989 Sep; 53(3):698-704. PubMed ID: 2569500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine.
    Monaghan DT; Olverman HJ; Nguyen L; Watkins JC; Cotman CW
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9836-40. PubMed ID: 2904680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
    Greenamyre JT; Penney JB; D'Amato CJ; Young AB
    J Neurochem; 1987 Feb; 48(2):543-51. PubMed ID: 2878980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective association of N-methyl aspartate and quisqualate types of L-glutamate receptor with brain postsynaptic densities.
    Fagg GE; Matus A
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6876-80. PubMed ID: 6149551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced D-[3H]aspartate binding in Down's syndrome brains.
    Simpson MD; Slater P; Cross AJ; Mann DM; Royston MC; Deakin JF; Reynolds GP
    Brain Res; 1989 Apr; 484(1-2):273-8. PubMed ID: 2540884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous ligands for the quisqualate receptor: presence in rat brain cortex synaptic vesicles.
    Villanueva S; Orrego F
    Brain Res; 1988 Feb; 440(2):363-5. PubMed ID: 2896048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.